---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-249206"
form_type: "8-K"
ticker: "VTRS"
cik: "0001792044"
company_name: "Viatris Inc"
filed_at: "2023-10-02T23:59:59+00:00"
generated_at: "2026-06-10T06:27:46.878360+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Viatris enters agreement to sell OTC business to Cooper Consumer Health for up to €1.95B

## Summary
- Up to €1.95B cash consideration: €1.85B at closing plus up to €100M contingent on return multiple.
- Option exercisable by Viatris after employee consultations; expires Feb 2, 2024.
- Closing subject to regulatory approvals from EU Commission, Serbia, France, and Italy.
- Viatris to provide transition services; €25M advance payment at closing for TSA fees.
- €120M of consideration retained by buyer for future sale of select geographies.

## SEC filing metadata
- accession: 0001193125-23-249206
- form_type: 8-K
- ticker: VTRS
- cik: 0001792044
- company_name: Viatris Inc
- filed_at: 2023-10-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1792044/000119312523249206/0001193125-23-249206-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1792044/000119312523249206/d470098d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-249206
- JSON: https://secwatch.observer/filing/0001193125-23-249206.json
- Plain text: https://secwatch.observer/filing/0001193125-23-249206.txt

## Key facts
- Material Agreements
  Viatris Inc entered into Transaction Agreement with Cooper Consumer Health SAS valued at up to €1,950.0 million (effective 2023-10-01).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: Cooper Consumer Health SAS
  - Value: up to €1,950.0 million
  - Effective: 2023-10-01
  source text: On October 1,2023, Viatris Inc., a Delaware corporation (“ Viatris ” or the “ Company ”) entered into an agreement with Cooper Consumer Health SAS, a French corporation (“ Buyer Parent ”) pursuant to which Buyer Parent made a binding offer (“ the Offer ”), by irrevocably granting Viatris an option (the “ Option ”), to require the Buyer Parent and certain of its affiliates (collectively, the “ Buyer Parties ”) to purchase and assume, as applicable, substantially all of Viatris’ over-the-counter products business (the “ Business ”) and related assets and liabilities, on the terms and subject to the conditions of a negotiated form of Transaction Agreement described below (such form, the “ Transaction Agreement ” and such potential transaction, the “ Transaction ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1792044/000119312523249206/0001193125-23-249206-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.